For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Vitamin D Group | Patients receiving vitamin D supplement (2000 IU/day) for 2 months Vitamin D No serious adverse events noted. | 0 | None | 0 | 75 | 3 | 75 | View |
| Control Group | Patients without receiving vitamin D supplement No serious adverse events noted. | 0 | None | 0 | 74 | 6 | 74 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| tearing | SYSTEMATIC_ASSESSMENT | Eye disorders | None | View |
| urine occult blood positive | NON_SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| dyspnea | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| skin rash | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| sneezing | NON_SYSTEMATIC_ASSESSMENT | Ear and labyrinth disorders | None | View |
| acid reflux | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| leg soreness | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |